Influência da lipoproteína (a) trombólise com rt-PA no infarto do miocárdio
Santos Filho, Raul Dias dos; Tranchesi Júnior, Bernardino; Caramelli, Bruno; Barbosa, Vânia; Gebara, Otávio; Albuquerque, Cícero P. de; Vinagre, Carmem; Maranhäo, Raul; Pileggi, Fúlvio.
Arq. bras. cardiol
; 57(1): 9-12, jul. 1991. tab, ilus
Artigo em Português | LILACS | ID: lil-107901
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
Systemic fibrinolysis through intraosseous vascular access in ST-segment elevation myocardial infarction.
Thrombolytic therapy-associated acute myocardial infarction in patients with acute ischemic stroke: A treatment dilemma.
Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian Registry.
[A randomized clinical trial on comparison of weight-adjusted dose with low dose recombinant tissue-type plasminogen activator on Chinese patients with acute myocardial infarction].
[An angiographic trial to evaluate the efficacy and safety of tenecteplase in Chinese patients with acute myocardial infarction].
Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
A case series of prosthetic heart valve thrombosis-derived coronary embolism.
A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction.